DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The "Transfection Reagent And Equipment Market Size, Share, & Trends Analysis Report By Product, By Method, By Application (Gene Expression, Protein Production, Cancer Research, Therapeutics), And Segment Forecasts, 2014 - 2022" report has been added to ResearchAndMarkets.com's offering.

The global transfection reagent & equipment market size is expected to reach USD 1.08 billion by 2022, progressing at a CAGR of 7.4%.

The growth of the market can be attributed to ongoing oncology-based research & development that aimed at understanding disease cause at genomic & molecular levels coupled with consequent surging demand for targeted therapies.

Transfection technology is recognized as an integral part of research programs pertaining to thorough investigation of various chromosomal anomalies. Hence, rising cancer prevalence of cancer as well as genetic conditions is anticipated to provide a fillip to the market. Furthermore, funds and grants by funding and government bodies are likely to back the growth of the market.

Funding and federal agencies, such as National Science Foundation (NSF), are offering the biotechnology sector with huge funding to carry out their biotechnology-based investigational studies. Moreover, international funding bodies such as NIH and Welcome Trust are projected to play a crucial role in the growth of the market by providing funds for genetic research studies. Such significant funds and grants are poised to boost the adoption of transfection technology over the forecast period.

Thermo Fisher Scientific Inc., Promega Corporation, QIAGEN, and F.Hoffmann-La Roche Ltd are some prominent players in the market. These companies are undertaking several endeavors to enhance their shares in the market

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Transfection Reagents & Equipment Industry Outlook

Chapter 4 Transfection Reagents & Equipment Product Outlook

Chapter 5 Transfection Reagents & Equipment Method Outlook

Chapter 6 Transfection Reagents & Equipment Application Outlook

Chapter 7 Transfection Reagents & Equipment Regional Outlook

Chapter 8 Competitive Landscape

Thermo Fisher Scientific Inc Promega Corporation Lonza AG Qiagen Mirus Bio LLC EMD Millipore Bio-Rad Laboratories Inc. OriGene Technologies Inc. Merck KgaA

For more information about this report visit https://www.researchandmarkets.com/research/2ckcgf/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005691/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 01:33 PM/DISC: 08/30/2018 01:33 PM

http://www.businesswire.com/news/home/20180830005691/en